<?xml version="1.0" encoding="UTF-8"?>
<ref id="B46" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Singh</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kalia</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Joshi</surname>
    <given-names class="given-names">P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kumar</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sharma</surname>
    <given-names class="given-names">P. R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kumar</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <etal class="etal"/>
  </person-group> (
  <year class="year">2017</year>). 
  <article-title class="article-title">Boeravinone B, novel dual inhibitors of NorA bacterial efflux pump of 
   <italic class="italic">Staphylococcus aureus</italic> and human P-glycoprotein, reduces the biofilm formation and intracelular invasi√≥n of bacteria.
  </article-title>
  <source class="source">
   <italic class="italic">Front. Microbiol.</italic>
  </source>
  <volume class="volume">8</volume>:
  <issue class="issue">1868</issue>
  <pub-id pub-id-type="doi" class="pub-id">10.3389/fmicb.2017.01868</pub-id>
 </mixed-citation>
</ref>
